AKT1 and ovarian carcinoma: Apatinib also suppresses the proliferation, metastasis and induces apoptosis in many cancer cells, such as ovarian cancer cells, gastric cancer cells and cholangiocarcinoma cells, by inhibiting PI3K/AKT signaling pathways (13, 26, 27).